DGE’s Next-Gen MSL Excellence Symposium Is The First-Ever Virtual Industry Event To Focus On The Work Challenges Faced By Medical Science Liaisons

June 9, 2021 08:30:49
Date: June 23-24, 2021 Virtual Conference Medical Science Liaisons (“MSLs”), along with pharma companies and other life science professionals, are invited to attend DGE’S inaugural Next-Gen MSL Excellence Symposium being held on June 23-24, 2021. This symposium is the only virtual industry event to focus on the work challenges faced by MSLs, to emphasize the importance of their role in drug and device development and adapting to new technologies in the Post-COVID scenario. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing b2b events. The world-class event company is an industry leader meeting the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries. MSLs are vital to the successful development of drugs and medical devices. They need to keep abreast with the latest research and development and adapt themselves to the evolving technologies, key to successful product utilization. The most important aspect of an MSL’s job is to maintain peer-to-peer relationships with KOLs (Key Opinion Leaders), meaning physicians, clinicians, and academic leaders at institutes, pharma companies, hospitals, and research centers. In addition, for the first time, a conference will focus on the pivotal role of MSLs and the work challenges faced by them. DGE’S Next-Gen MSL Excellence Symposium will offer a dynamic platform for the medical industry KOLs and decision-makers to come together and share their opinions and discuss the role of MSLs in the changing scenario. They will also offer valuable tips and techniques to build a successful MSL career and demonstrate the value of skills to the organization. The agenda of the Symposium includes the following discussion points:
  • Improving the skills of MSL personnel for a successful career
  • Utilizing business acumen, communication, and interpersonal skills to attain success
  • Understanding the needs of an HCP and communicating complex scientific data effectively
  • Avoiding burnout and managing work-life balances
  • Impact of MSLs on the overall performance of an organization
  • Engagement and collaboration with stakeholders and clinical development teams
  • Managing virtual and hybrid engagements
This symposium also presents a wonderful opportunity for bright professionals working toward a lucrative MSL career. Medical Affairs professionals will interact with similar teams to learn new and expansive ideas and roles. To know more about the event, please visit https://ibn.fm/Zqhpr.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.